6533b854fe1ef96bd12adfb1
RESEARCH PRODUCT
Role of adipokines signaling in the modulation of T cells function
Claudio EprocacciniClaudio EprocacciniVeronica Ede RosaVeronica Ede RosaVeronica Ede RosaMario GalganiFortunata EcarboneFortunata EcarboneClaudia Ela RoccaClaudia Ela RoccaLuigi FormisanoGiuseppe Emataresesubject
Leptinlcsh:Immunologic diseases. AllergyobesityImmunologyT cellsAdipose tissueAdipokineContext (language use)Review Articlemedicine.disease_cause03 medical and health sciences0302 clinical medicineImmune systemmedicineImmunology and Allergy030304 developmental biologyobesity.0303 health sciencesbusiness.industryLeptinLipid metabolismImmune dysregulationmedicine.disease3. Good health030220 oncology & carcinogenesisadipocytokinesImmunologyAdiponectinMetabolic syndromebusinesslcsh:RC581-607description
The field that links immunity and metabolism is rapidly expanding. Apparently non-immunological disorders such as obesity and type 2 diabetes have been linked to immune dysregulation, suggesting that metabolic alterations can be induced by or be consequence of an altered self-immune tolerance. In this context, adipose tissue produces and releases a variety of pro-inflammatory and anti-inflammatory factors, termed "adipokines," which can be considered as the bridge between obesity-related exogenous factors, such as nutrition and lifestyle, and the molecular events leading to metabolic syndrome, inflammatory, and/or autoimmune conditions. In obesity, increased production of most adipokines impacts on multiple functions such as appetite and energy balance, modulation of immune responses, insulin sensitivity, angiogenesis, blood pressure, lipid metabolism, and so on. This report aims to discuss some of the recent topics of adipocytokine research and their related signaling pathways, that may be of particular importance as could lead to effective therapeutic strategies for obesity-associated diseases.
year | journal | country | edition | language |
---|---|---|---|---|
2013-10-01 | Frontiers in Immunology |